Rexulti 1 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FFHV4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,864
Award facts
- Contract value 100% obligated
- $25,863.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order awards $25,863.70 to AmerisourceBergen Drug Corp for the supply of REXULTI (brexpiprazole) 1 mg tablets in a 30-count package. The contract, which is not set-aside, was competitively awarded by the Defense Logistics Agency (DLA) on September 9, 2025, with an ultimate completion date of September 10, 2025. The firm fixed price contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. REXULTI is an atypical antipsychotic medication used primarily for the treatment of schizophrenia and major depressive disorder, representing a critical pharmaceutical supply need for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. That prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. The company's status as a major pharmaceutical distributor and critical federal medical procurement vendor positions it to efficiently fulfill federal medication requirements across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FFHV4?
SPE2DB25FFHV4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FFHV4 worth?
The government has obligated $25,864 on SPE2DB25FFHV4.
Is contract SPE2DB25FFHV4 an order under another contract?
Yes. SPE2DB25FFHV4 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFHV4 competed?
The extent of competition for SPE2DB25FFHV4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award